A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia

Infectious Diseases
COVID-19 Pneumonia

Results
Download
Print

Study results

EMPACTA_ML42528_layperson-summary_Oct2020_English (PDF, 0.7 MB)

LPS ML42528 LOPAC Final Results September 2023 English (PDF, 0.4 MB)

LPS ML42528 LOPAC Final Results September 2023 LA Spanish (PDF, 0.4 MB)

LPS ML42528 LOPAC Final Results September 2023 Kenya Swahili (PDF, 0.5 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia

Study results

EMPACTA_ML42528_layperson-summary_Oct2020_English (PDF, 0.7 MB)

LPS ML42528 LOPAC Final Results September 2023 English (PDF, 0.4 MB)

LPS ML42528 LOPAC Final Results September 2023 LA Spanish (PDF, 0.4 MB)

LPS ML42528 LOPAC Final Results September 2023 Kenya Swahili (PDF, 0.5 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia

For the latest version of this information please go to www.forpatients.roche.com